US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Definium Therapeutics

16.90

+0.65004.00%

Post-market: 16.900.00000.00%19:58 EST

Volume:1.17M

Turnover:19.67M

Market Cap:1.66B

PE:-8.55

High:17.02

Open:16.49

Low:16.46

Close:16.25

52wk High:18.70

52wk Low:4.70

Shares:98.51M

Float Shares:91.33M

Volume Ratio:0.62

T/O Rate:1.28%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.9758

EPS(LYR):-1.5424

ROE:-85.59%

ROA:-33.95%

PB:12.75

PE(LYR):-10.96

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

LSD therapy biotech Definium sued for alleged trade secret theft

Definium Therapeutics Grants Stock Options to New Employees

Definium Therapeutics Initiated at Buy by Jefferies

Jefferies Initiates Coverage on Definium Therapeutics With Buy Rating, $30 Price Target

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/DFTX"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"DFTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DFTX\",,,,,undefined,":{"symbol":"DFTX","market":"US","secType":"STK","nameCN":"Definium Therapeutics","latestPrice":16.9,"timestamp":1770411600000,"preClose":16.25,"halted":0,"volume":1172450,"hourTrading":{"tag":"盘后","latestPrice":16.9,"preClose":16.9,"latestTime":"19:58 EST","volume":13454,"amount":227299.833,"timestamp":1770425887977,"change":0,"changeRate":0,"amplitude":0.012124},"delay":0,"changeRate":0.03999999999999991,"floatShares":91334800,"shares":98509279,"eps":-1.975783,"marketStatus":"Market Closed","change":0.65,"latestTime":"02-06 16:00:00 EST","open":16.49,"high":17.015,"low":16.46,"amount":19672940.70035,"amplitude":0.034154,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.975783,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1770627600000},"marketStatusCode":7,"adr":0,"exchange":"NASDAQ","adjPreClose":16.25,"preHourTrading":{"tag":"盘前","latestPrice":16.42,"preClose":16.25,"latestTime":"09:28 EST","volume":1888,"amount":30718.25088,"timestamp":1770388080069,"change":0.17,"changeRate":0.010462,"amplitude":0.070154},"postHourTrading":{"tag":"盘后","latestPrice":16.9,"preClose":16.9,"latestTime":"19:58 EST","volume":13454,"amount":227299.833,"timestamp":1770425887977,"change":0,"changeRate":0,"amplitude":0.012124},"volumeRatio":0.6223328780544038,"impliedVol":0.8186,"impliedVolPercentile":0.4},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DFTX\",,,,,undefined,":{"symbol":"DFTX","floatShares":91334800,"roa":"-33.95%","roe":"-85.59%","lyrEps":-1.542397,"volumeRatio":0.6223328780544038,"shares":98509279,"dividePrice":0,"high":17.015,"amplitude":0.034154,"preClose":16.25,"low":16.46,"week52Low":4.7,"pbRate":"12.75","week52High":18.7,"institutionHeld":0,"latestPrice":16.9,"eps":-1.975783,"divideRate":0,"volume":1172450,"delay":0,"ttmEps":-1.975783,"open":16.49,"prevYearClose":13.39,"prevWeekClose":16.88,"prevMonthClose":16.88,"prevQuarterClose":13.39,"fiveDayClose":16.88,"twentyDayClose":14.7,"sixtyDayClose":11.75},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DFTX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DFTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DFTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2857,"buy":0.7143,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.7143,"analysts":14,"updateTime":1769749200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/DFTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"DFTX","date":"2026-02-05","current":-8.553571,"percent":0.428571,"low":-10.683198,"twenty":-10.206175,"median":-9.944809,"eighty":-9.542797,"high":-8.802064,"avg":-9.839715,"sd":0.541634,"marketCap":1677613021},"quantilePoints":[{"date":"2026-01-16","current":-9.013032,"twenty":-8.970838,"median":-8.907548,"eighty":-8.844258,"marketCap":1515072711},{"date":"2026-01-23","current":-9.944809,"twenty":-9.944809,"median":-9.423248,"eighty":-8.819645,"marketCap":1671702464},{"date":"2026-01-30","current":-10.103035,"twenty":-10.103035,"median":-9.868626,"eighty":-9.013032,"marketCap":1698299969},{"date":"2026-02-05","current":-9.97997,"twenty":-10.206175,"median":-9.944809,"eighty":-9.542797,"marketCap":1677613021}],"updateTime":1770428293421},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DFTX\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2608281396","title":"LSD therapy biotech Definium sued for alleged trade secret theft","url":"https://stock-news.laohu8.com/highlight/detail?id=2608281396","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608281396?lang=en_us&edition=fundamental","pubTime":"2026-02-03 06:05","pubTimestamp":1770069917,"startTime":"0","endTime":"0","summary":"LSD therapy biotechDefinium sued for alleged trade secret theftBy Blake BrittainFeb 2 (Reuters) - A clinical-trial provider sued psychedelic therapy developer Definium Therapeutics DFTX.O on Monday in","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260202:nL6N3YY14X:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"gpt_icon":0},{"id":"2608970328","title":"Definium Therapeutics Grants Stock Options to New Employees","url":"https://stock-news.laohu8.com/highlight/detail?id=2608970328","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608970328?lang=en_us&edition=fundamental","pubTime":"2026-02-03 05:00","pubTimestamp":1770066025,"startTime":"0","endTime":"0","summary":"Definium Therapeutics Inc. has announced the issuance of inducement grants to two newly hired non-executive employees. The grants consist of options to purchase a total of 28,640 common shares, with an effective grant date of February 2, 2026. The options will vest over four years: 25% will vest on the first anniversary of the grant date, and the remaining 75% will vest in equal monthly increments over the subsequent three years. The exercise price for the options is set at the closing price of Definium’s common shares on the grant date.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Definium Therapeutics Inc. published the original content used to generate this news brief via Business Wire  on February 02, 2026, and is solely responsi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260202:nNDL1lPJh8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DFTX","BK4007"],"gpt_icon":0},{"id":"2607702998","title":"Definium Therapeutics Initiated at Buy by Jefferies","url":"https://stock-news.laohu8.com/highlight/detail?id=2607702998","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607702998?lang=en_us&edition=fundamental","pubTime":"2026-01-31 04:34","pubTimestamp":1769805240,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/DFTX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 30, 2026 15:34 ET (20:34 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","DFTX"],"gpt_icon":0},{"id":"2607010704","title":"Jefferies Initiates Coverage on Definium Therapeutics With Buy Rating, $30 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2607010704","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607010704?lang=en_us&edition=fundamental","pubTime":"2026-01-30 20:28","pubTimestamp":1769776130,"startTime":"0","endTime":"0","summary":"Definium Therapeutics, Inc. (DFTX) has an average rating of Buy and mean price target of $31.85, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research fr","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["DFTX"],"gpt_icon":0}],"pageSize":4,"totalPage":5,"pageCount":1,"totalSize":20,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/DFTX\",params:#limit:6,delay:false,,,undefined,":[]}}